Insights from 2023 ASCO® Annual Meeting

 

GU
11:37

Insights from 2023 ASCO® Annual Meeting

Assessment and Decision Tools for Balancing Survival and Quality of Life

FEATURING Elizabeth Kessler
  • 94 views
  • October 3, 2023
07:44

Insights from 2023 ASCO® Annual Meeting

Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in Patients With mCRPC: Final Analysis of ORR, rPFS, and OS

FEATURING Julie Graff, Alexandra Sokolova
  • 341 views
  • September 12, 2023
09:57

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Prospective Trial of Apalutamide & Abiraterone Acetate + Prednisone in Black and White Men With mCRPC"

FEATURING Daniel George
  • 261 views
  • August 2, 2023
  • 2
09:59

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Determinants of Resistance to Nivo Monotherapy Investigated Through Genomic and Transcriptomic Analysis of RCC Tumors From the HCRN GU16-260 Study"

FEATURING David Braun
  • 70 views
  • July 12, 2023
17:48

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Combination Therapies Come of Age in Kidney Cancer"

FEATURING David Braun
  • 50 views
  • July 12, 2023
03:49

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "HR-QoL Measures in RCC - Patient-Reported Relevance of Items of the FKSI-19, EORTC QLQ-C30, and EQ-5D"

FEATURING Cristiane Decat Bergerot
  • 31 views
  • July 1, 2023
15:15

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Discussion of LBA4619, Phase 3 THOR Study - Results of Erdafitinib vs. Chemo in Advanced/Metastatic UC With Select FGFR Alterations (The Emerging Role of Targeted Therapy)"

FEATURING Daniel Petrylak
  • 89 views
  • July 1, 2023
16:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/Recurrent NSGCT Patients"

FEATURING Edmund Waller
  • 115 views
  • June 29, 2023
  • 3
11:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR - 4-Year Follow-Up of Lenvatinib + Pembro vs. Sunitinib in Patients With Advanced RCC"

FEATURING Thomas Hutson
  • 300 views
  • June 27, 2023
09:59

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "When to Play the Systemic Therapy Card in Oligometastatic RCC"

FEATURING Karie Runcie
  • 145 views
  • June 23, 2023
23:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With Renal Cell Carcinoma"

FEATURING Bradley McGregor
  • 454 views
  • June 22, 2023
  • 3
06:13

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Analysis of Real-World Treatment Outcomes of 1L Axitinib + Pembrolizumab in Pts With Advanced RCC in the United States"

FEATURING Yousef Zakharia
  • 145 views
  • June 21, 2023
07:10

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Use of ctDNA to Complement Tumor Tissue HRR Gene Alteration Testing in TALAPRO-2, A Phase 3 Study of Talazoparib + Enza vs. Placebo + Enza as 1L Treatment for mCRPC"

FEATURING Arun Azad
  • 36 views
  • June 20, 2023
04:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Safety Analyses From the Randomized, Placebo-Controlled, Phase 3 TALAPRO-2 Study - Talazoparib + Enzalutamide in mCRPC"

FEATURING Arun Azad
  • 223 views
  • June 20, 2023
13:54

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Key Bladder Cancer/Urothelial Carcinoma Updates"

FEATURING Guru Sonpavde
  • 376 views
  • June 16, 2023
  • 2
17:23

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMA-PET Imaging Case Studies and Sequencing Discussions in Prostate Cancer"

FEATURING Phuoc Tran
  • 630 views
  • June 16, 2023
  • 2
16:52

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of Phase 3 PEACE-1 Randomized Trial With a 2x2 Design - Prostate Irradiation in Men With De Novo, Low-Volume, mCSPC"

FEATURING Alberto Bossi
  • 56 views
  • June 15, 2023
  • 1
09:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozantinib + Nivolumab for Patients With mRCC - A Randomized Clinical Trial"

FEATURING Hedyeh Ebrahimi
  • 106 views
  • June 14, 2023
07:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Host Immune Signatures With Response to IO-Based Regimens in Patients With mRCC"

FEATURING Eddy Saad
  • 89 views
  • June 12, 2023
05:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Trial - Neoadjuvant Treatment With Enfortumab Vedotin Monotherapy in Cisplatin-Ineligible Patients With MIBC"

FEATURING Thomas Flaig
  • 111 views
  • June 12, 2023
08:59

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Poster Sessions From Dr. Andrew Armstrong in Prostate Cancer: PANTHER, STARTAR, and HOXB13 Biomarker

FEATURING Andrew Armstrong
  • 523 views
  • June 12, 2023
  • 2
07:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Development & Validation of an AI-Derived Digital Pathology-Based Biomarker to Predict Benefit of Long-Term ADT With RT in Men With Localized HR-PC Across Multiple Phase 3 Trials"

FEATURING Andrew Armstrong
  • 61 views
  • June 12, 2023
09:44

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Safety of Avelumab 1L Maintenance for aUC in the JAVELIN Bladder 100 Trial"

FEATURING Joaquim Bellmunt
  • 84 views
  • June 9, 2023
  • 1
10:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Preliminary Results of Arm B5 of the Phase 1/2 KEYMAKER-U03B Study - Belzutifan + Lenvatinib for Pts With Advanced ccRCC After Progression on a PD-1/L1 & VEGF Inhibitor"

FEATURING Laurence Albiges
  • 100 views
  • June 9, 2023
19:50

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Adding Clarity to Non-Clear Cell Carcinoma"

FEATURING Manuela Schmidinger
  • 295 views
  • June 9, 2023
  • 1
09:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Enfortumab Vedotin +/- Pembro in Pts Who Are Cisplatin-Ineligible With Previously Untreated Locally Advanced or mUC - Additional 3-Month Follow-Up on Cohort K Data"

FEATURING Terence Friedlander
  • 235 views
  • June 8, 2023
  • 2
07:42

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 Phase 3 Trial - Outcomes of Black vs. White Patients With mHSPC Treated With ADT With or Without Orteronel"

FEATURING Nicolas Sayegh
  • 80 views
  • June 8, 2023
11:46

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Term Outcome of EV + Pembro in 1L Cisplatin-Ineligible Stage 3/4 UC With Nearly 4 Years of Follow-Up"

FEATURING Shilpa Gupta
  • 215 views
  • June 8, 2023
05:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treatment With 177Lu-PSMA-617 + SoC & SoC Alone in Pts With mHSPC"

FEATURING Scott Tagawa
  • 1,781 views
  • June 8, 2023
  • 3
09:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Advanced RCC With Variant Histology"

FEATURING Bradley McGregor
  • 701 views
  • June 8, 2023
  • 1
08:22

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzumab Govitecan by Trop-2 Expression and UGT1A1 Status in the TROPHY-U-01 Study for LA or mUC"

FEATURING Scott Tagawa
  • 165 views
  • June 8, 2023
08:25

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase I Dose-Escalation Results of PSMA-TRT With Alpha-Radiolabeled Antibody 225Ac-J591 and Beta-Radioligand 177Lu-PSMA I&T"

FEATURING Scott Tagawa
  • 165 views
  • June 8, 2023
05:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR3 Alterations in Phase III PROOF 302 Trial: Infigratinib (BGJ398) as Adjuvant Therapy in Patients With Invasive Urothelial Carcinoma"

FEATURING Petros Grivas
  • 181 views
  • June 6, 2023
09:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 Study of Batiraxcept (AVB-S6-500) as Monotherapy, in Combination With Cabo, and in Combination With Cabo & Nivo in Patients With Advanced/Metastatic ccRCC"

FEATURING Katy Beckermann
  • 130 views
  • June 6, 2023